IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q2 2021 Holdings

Filed 2021-08-13 | 13 holdings | $34.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$33.8M97,52399.2%
Regeneron Pharmaceuticals(REGN)COM75886F107$45.9K82,1040.1%
Alkermes PLC(ALKS)COMG01767105$41.4K1,688,8410.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$41.4K939,6500.1%
United Therapeutics Corp(UTHR)COM91307C102$39.4K219,6900.1%
Taro Pharmaceutical IndusCOMM8737E108$39.1K543,7050.1%
Mckesson Corp(MCK)COM58155Q103$31.8K166,4360.1%
Surgalign Holdings IncCOM86882C105$8.9K6,403,0770.0%
Invacare CorpCOM461203101$7.3K901,7120.0%
Eagle Pharmaceuticals Inc(EGRX)COM269796108$3.0K70,8040.0%
Travere Therapeutics Inc(TVTX)COM89422G107$2.0K140,0000.0%
Anaptysbio Inc(ANAB)COM032724106$28210,8900.0%
Nextcure IncCOM65343E108$25231,3550.0%